SARS-CoV-2 infection and COVID-19 vaccination in pregnancy.
SARS-CoV-2 infection and COVID-19 vaccination in pregnancy.
复制标题
妊娠期SARS-CoV-2感染和COVID-19疫苗接种。
DOI：
10.1038/s41577-022-00703-6
复制
发表时间：
2022-05
期刊：
影响因子：
--
通讯作者：
Male V
中科院分区：
文献类型：
--
作者：
Male V
SARS-CoV-2 感染会增加妊娠期间不良结局的风险，包括早产和死产。人们还越来越担心 SARS-CoV-2 感染对胎盘的影响，而且这些影响似乎因不同病毒变种而异。尽管存在这些风险，但出于安全考虑，许多孕妇仍不愿接种该病毒疫苗。我们现在拥有大量数据证实怀孕期间接种 COVID-19 疫苗的安全性和有效性，尽管还需要确定这些疫苗专门针对新出现的病毒变体（包括 Omicron）的有效性。在这篇进展文章中，我介绍了我们对妊娠期 SARS-CoV-2 感染风险的理解的最新进展，以及疫苗接种如何减少这些风险。在这篇进展文章中，Male 总结了我们目前对妊娠期 SARS-CoV-2 感染相关风险的了解。重要的是，本文强调了目前有大量证据支持怀孕期间接种 COVID-19 疫苗的安全性和有效性。
SARS-CoV-2 infection poses increased risks of poor outcomes during pregnancy, including preterm birth and stillbirth. There is also developing concern over the effects of SARS-CoV-2 infection on the placenta, and these effects seem to vary between different viral variants. Despite these risks, many pregnant individuals have been reluctant to be vaccinated against the virus owing to safety concerns. We now have extensive data confirming the safety and effectiveness of COVID-19 vaccination during pregnancy, although it will also be necessary to determine the effectiveness of these vaccines specifically against newly emerging viral variants, including Omicron. In this Progress article, I cover recent developments in our understanding of the risks of SARS-CoV-2 infection in pregnancy, and how vaccination can reduce these. In this Progress article, Male summarizes our current understanding of the risks associated with SARS-CoV-2 infection in pregnancy. Importantly, the article highlights the now substantial body of evidence supporting the safety and efficacy of COVID-19 vaccination in pregnancy.
登录
查看更多内容
DOI：
10.15585/mmwr.mm7107e3
发表时间：
2022-02-18
期刊：
MMWR. Morbidity and mortality weekly report
影响因子：
--
作者：
Halasa NB;Olson SM;Staat MA;Newhams MM;Price AM;Boom JA;Sahni LC;Cameron MA;Pannaraj PS;Bline KE;Bhumbra SS;Bradford TT;Chiotos K;Coates BM;Cullimore ML;Cvijanovich NZ;Flori HR;Gertz SJ;Heidemann SM;Hobbs CV;Hume JR;Irby K;Kamidani S;Kong M;Levy ER;Mack EH;Maddux AB;Michelson KN;Nofziger RA;Schuster JE;Schwartz SP;Smallcomb L;Tarquinio KM;Walker TC;Zinter MS;Gilboa SM;Polen KN;Campbell AP;Randolph AG;Patel MM;Overcoming COVID-19 Investigators;Overcoming COVID-19 Network
通讯作者：
Overcoming COVID-19 Network
影响因子：
30.5
作者：
Gee, Sarah;Chandiramani, Manju;Gibbons, Deena L.
通讯作者：
Gibbons, Deena L.
影响因子：
13.8
作者：
Edlow AG;Li JZ;Collier AY;Atyeo C;James KE;Boatin AA;Gray KJ;Bordt EA;Shook LL;Yonker LM;Fasano A;Diouf K;Croul N;Devane S;Yockey LJ;Lima R;Shui J;Matute JD;Lerou PH;Akinwunmi BO;Schmidt A;Feldman J;Hauser BM;Caradonna TM;De la Flor D;D'Avino P;Regan J;Corry H;Coxen K;Fajnzylber J;Pepin D;Seaman MS;Barouch DH;Walker BD;Yu XG;Kaimal AJ;Roberts DJ;Alter G
通讯作者：
Alter G
影响因子：
120.7
作者：
Collier, Ai-ris Y.;McMahan, Katherine;Barouch, Dan H.
通讯作者：
Barouch, Dan H.
影响因子：
3.6
作者：
Dahlgren, Jovanna;Samuelsson, Anne-Maj;Holmang, Agneta
通讯作者：
Holmang, Agneta